Mixed venous oxygen saturation (SvO2) is a physiologic parameter reflecting cardiac output (CO) and tissue oxygen utilization. An implantable oxygen sensor incorporated in a right ventricular pacing lead has been developed to assess the feasibility of ambulatory monitoring of SvO2 to predict cardiorespiratory parameters.
Mixed venous oxygen saturation (SvO2) is a physiologic parameter reflecting cardiac output (CO) and tissue oxygen utilization. An implantable oxygen sensor incorporated in a right ventricular pacing lead has been developed to assess the feasibility of ambulatory monitoring of SvO2 to predict cardiorespiratory parameters.
Eight patients with a mean age of 62 ± 2 years and sinoatrial disease received an SvO2-driven dual-chamber rate-adaptive pacemaker capable of continuous SvO2 measurement. During graded maximal exercise with measurement of oxygen consumption (Vo2), arterial oxygen saturation (SaO2), and telemetered derived SvO2 data, CO was assessed using the Fick principle. The accuracy of the derived CO was compared with CO measured directly by continuous-wave Doppler assessment of the ascending aortic flow. The maximum changes in SvO2 and SaO2 during exercise were 25 ± At 25 mm from the ventricular pacing electrode, an oxygen sensor is incorporated that detects SvO2 by the principle of reflectometry. The technical details of the SvO2 sensor have been reported. 15 In brief, it consists of red (660 nm) and infrared (880 nm) light-emitting diodes, hermetically sealed in a sapphire capsule. The reflectance of the light from each is received and measured by a photodetector to generate a relative reflectance ratio. This ratio varies in proportion to changes in right ventricular SvO2. The use of a reflectance ratio instead of reflectance from a single wavelength has been shown to reduce the variation in SvO2 determination resulting from fibrin coating, intrasystolic variation, velocity of blood flow, ventricular wall proximity, and changes in hematocrit. The SvO2 was sampled, once every 4 s, synchronized to an R wave. The lead is connected to the pacemaker via an IS-1 in-line "bipolar-like" (unipolar ventricular pacing and sensing, SvO2 parameters) connection.
Dual-Sensor Dual-Chamber Rate-Adaptive Pacemaker
The pacemaker (OxyElite, model 8007, Medtronic Inc) is based on an activity-sensing DDDR pacemaker from the same manufacturer (Elite IL, model 7086).14 It can be programmed to provide rate response either using a right ventricular SvO2 sensor or a piezoelectric activity sensor. The pacemaker features both activity and SvO2 telemetry (in real time), and it will also collect data for programmer display and storage of SvO2 values. On-line sensor data can be obtained by telemetry even in the DDD mode with the sensor programmed passive.
Because patients have different levels of SvO2 at rest, the "resting rate offset" (1-31, in steps of 1) is used to establish the point from which oxygen rate response can begin as well as the desired pacing rate at rest. Once the resting rate offset is exceeded, the desired rate response can be programmed using a rate response curve, the so-called "oxygen rate response" (1-16, in steps of 1). A linear relation is used to relate a change in SvO2 to a change in rate (bpm/02%). For the purpose of this study, the DDD mode was used, and only telemetry-derived SvO2 level was used for analysis. Pacemaker Implantation and Sensor Validation
The implantation was similar to a conventional DDD pacemaker. As the position of the sensor precludes the passage of a stylet guidewire to the tip of the ventricular lead, more manipulation of the lead into the right ventricle was required. A satisfactory pacing and sensing position for both leads was achieved in all patients, with the sensor well within the right ventricular body. In five patients, a simultaneous right ventricular blood sample was taken to correlate with the telemetered derived SvO2 level (Fig 1) .
METHODS

Patients
Eight female patients with symptomatic sinoatrial disease received the dual-sensor DDDR pacemakers. All Figure 2 . FIGURE 1. Anteroposterior (AP) and left anterior oblique (LAO) radiographs of a patient during implantation of an oxygen-driven dual-chamber rate-adaptive pacemaker. The oxygen sensor was shown up radiographically as three radiopaque dots (lower arrows) proximal to the ventricular pacing electrode. A 6F multipurpose catheter (upper arrow) was advanced from the femoral vein into the right ventricle for simultaneous blood sampling. FIGURE 2. Experiment set-up to investigate the usefulness of an implanted oxygen sensor to predict cardiopulmonary parameters. The pieces of equipment include the following: (1) a metabolic cart to sample breath-by-breath gaseous exchanges; (2) a continuous-wave Doppler to measure CO by sampling ascending aortic blood flow; (3) a pulse oximeter to measure SaO2; and (4) an implanted oxygen sensor and pacemaker giving telemetryderived oxygen saturation data from the right ventricle. See text for details of data analysis.
Cardiopulmonary Exercise Testing
Graded treadmill exercise testing was performed using the "chronotropic assessment exercise protocol."'6 This protocol involves a gradually increasing work load in 2-min stages in a linear fashion, especially covering the low exercise level to cater for the less athletic pacemaker recipients. During treadmill exercise test, Vo2 was continuously measured with a breath-by-breath analysis, using a metabolic cart (model 2900 MMC, Sensormedics, Anaheim, Calif).17 Gaseous flow and volume are measured using a mass flow sensor that has monotonic curvilinear output characteristics as a function of flow, with the highest sensitivity at low-flow values. The resolution in detecting tidal volume changes is about 15 mL. Oxygen is analyzed using a zirconium oxide sensor with a fast response to changes in oxygen saturation (typically within 120 ms). The oxygen level is calibrated with 16% and 26% oxygen using a two-point calibration scheme. Carbon dioxide is measured using the principle of nondispersive infrared absorption technique. Carbon dioxide is passed through a sample cell in the path of infrared energy, and changes in the electrical signal are proportional to the carbon dioxide partial pressure. During a breath-by-breath assessment, the gas flow and partial pressures of oxygen and carbon dioxide are sampled at a frequency of 125 Hz, and the values are summed and averaged for each breath. A moving average of 20 s was used in the assessment of respiratory variables of Vo2 tidal volume, minute ventilation, carbon dioxide production, and respiratory rate. The system is integrated with an exercise treadmill (Quinton 5000, Seattle) and a pulse oximeter (Sat-Trak, Sensorimedics) to derive SaO2. 
RESULTS
The SvO2 level from the sensor at rest was within 2% of the simultaneous blood gas value. One patient had suboptimal sensor function immediately after implantation, and she was excluded from the exercise test. Respiratory gaseous exchange could not be performed in another patient for technical reasons. The remaining patients completed the study. Exercise was limited either by dyspnea or fatigue in all patients.
The changes in cardiac, respiratory, and oxygen saturation parameters are summarized in Table 1 (Fig 4) . At any point in exercise, minute distance in meters could be derived from the estimated CO (46.3 ± 10.7X estimated-CO+299.5 ± 138.4, r=0.77 + 0.10 p<0.05) or from SvO2 value (-25.2±0.67XSv02+ 2,435 + 471, r=0.83± 0.03, p<0.05).
DISCUSSION
Main Findings
This study examined the feasibility of using an implanted oxygen sensor to predict cardiopulmonary performance during exercise. A highly significant correlation between changes in SvO2 and CO, Vo2, minute ventilation, and work performance was found. Using exercise as a physiologic stress to increase CO, it was shown that changes in CO could be predicted from SvO2 value on an ambulatory basis.
SvO2 as a Monitor for Cardiovascular Function
In patients with impaired cardiac function, oxygen delivery to the tissues will be reduced, resulting in a widening of arteriovenous oxygen saturation difference. A major goal in the treatment of these patients is to improve oxygen delivery in accordance with Vo2. Oxygen delivery to the tissue is commonly measured by a floatation pulmonary artery catheter using the thermodilution principle. However, this technique may be limited in low-flow states or in the presence of tricuspid regurgitation and may cause undesirable volume expansion during repeated cardiac output sampling. In addition, cardiac output measurement alone may not reflect the interaction between tissue oxygen uptake and extraction. Thus, SvO2 has been suggested to be an alternative parameter to gauge oxygen delivery and uptake. In the intensive care setting, SvO2 has been shown to be a useful indicator of CO, particularly if normalized for oxygen uptake and hemoglobin level.9"10,21-30 These studies used either intermittent blood sampling for the pulmonary artery or fiberoptic method for SvO2 measurement, and could not be used in the ambulatory patients.
The development of implantable sensors for rate augmentation has now made an implantable SvO2 sensor a possibility. This study shows the usefulness of SvO2 to predict CO during exercise. The SvO2 data can be derived noninvasively and stored in the pacemaker memory over an extended period of time. Thus, it may be possible to use such data for monitoring progress and response of patients with impaired heart function to therapeutic measures. Only exercise was used as a stress to the cardiopulmonary function, and the range of SvO2 changes was relatively moderate in this group of patients with normal left ventricular performance. However, it has been reported that the accuracy of SvO2 to predict cardiac SvO2 showed significant linear relationship to Vo2, minute ventilation, and workload. All these variables have a high correlation to heart rate. Although not a primary end point of this study, these results suggest the usefulness of SvO2 for use in rate optimization as shown in previous studies.1114 '32 Limitations of Study This study has evaluated only the short-term performance of the sensor to monitor SvO2. For such a sensor to be useful to monitor ambulatory cardiopulmonary performance, its long-term stability requires more extensive evaluation. In a follow-up of a similar SvO2 sensor, Faerestrand and Ohm12 reported 1 of 14 sensor failures in a 15-month follow-up. One of our eight patients had a suboptimal sensor function, which might be related to the burying of the sensor into the ventricular myocardium, as reported separately.14 The change in SvO2 value derived from the sensor was only relative, and an invasive calibration will be required to reflect the actual SvO2 value during exercise, although the changes in relative SvO2 did correlate with CO changes. Inadequate mixing of venous blood cannot be excluded from the present study, although other investigators"1"3 have reported adequate mixing of venous blood as sampled in the right atrium. We have ensured the sensor was within the right ventricle during implantation and during subsequent echocardiogram.
CONCLUSION
Implantable sensors for rate-adaptive cardiac pacing may be used for purposes other than rate augmentation. SvO2 sensing, with its close association to cardiopulmonary performance and tissue oxygen extraction, showed promise to be a useful parameter for monitoring cardiopulmonary performance in ambulatory patients.
